There are 15,358 results relating to "Medicin Viagra-m"
Order by
|
Last updated:
1 February 2022
SPBill7AS062022
Budget (Scotland) Bill [AS AMENDED AT STAGE 2] CONTENTS Section P ART 1 F INANCIAL YEAR 2022/23 Use of resources etc. 1 The Scottish Administration 2 Direct-funded bodies 3 Borrowing by statutory bodies The Scottish Consolidated Fund 4 Overall cash authorisations 5 Contingency payments P ART 2 F INANCIAL YEAR 2023/24 6 Emergency arrangements P ART 3 M ISCE...
Last updated:
9 December 2021
SPBill07S062021
Budget (Scotland) Bill [AS INTRODUCED] CONTENTS Section P ART 1 F INANCIAL YEAR 2022/23 Use of resources etc. 1 The Scottish Administration 2 Direct-funded bodies 3 Borrowing by statutory bodies The Scottish Consolidated Fund 4 Overall cash authorisations 5 Contingency payments P ART 2 F INANCIAL YEAR 2023/24 6 Emergency arrangements P ART 3 M ISCELLANEOUS...
Official Report
Meeting date:
14 May 2019
Economy, Energy and Fair Work Committee 14 May 2019
Use of the word “commercial” narrows the scope, because of the reasons to which Andy Wightman alluded and because commercial dynamics mean that investment in one area might turn up in another area. The classic example is Viagra, which was meant to be used for heart problems, not meant for what it is used currently.
Questions and Answers
Date answered:
17 July 2018
S5W-17457
To ask the Scottish Government how many Scotland-domiciled students have studied (a) medicine, (b) nursing and (c) allied health professional courses in each year since 2007.
Questions and Answers
Date answered:
21 November 2016
S5W-04619
In Scotland, we have a clear and consistent route for new drugs to be appraised through the long standing independent Scottish Medicines Consortium (SMC). There are a number of medicines which have been accepted by the SMC for routine use within the NHS in Scotland for the treatment of cancer.
Last updated:
2 November 2020
SPCBMinutes20201001
M inute of the Scottish Parliamentary Corporate Body (SPCB) meeting held on Thursday 1 October 2020 at 9.00am, in Q1.03 and via video conference (vc) Present: • Ken Macintosh MSP (Chair) • David Stewart MSP • Jackson Carlaw MSP • Liam McArthur MSP • Sandra White MSP • Andy Wightman MSP In attendance: • David McGill (vc) • Michelle Hegarty • Roy Devon (vc) ...
Last updated:
7 March 2023
BB20171123
Supported by: Gail Ross*, David Torrance*, Liam McArthur*, Liam Kerr* Members' Business motions that have not achieved cross party support *S5M-09067 Neil Findlay: Cystic Fibrosis and Medicines Access That the — Parliament understands that there are new medicines available to treat the underlying cause of cystic fibrosis, but is concerned that access to these is being delayed until negotiations on a portfolio of new cystic fibrosis drugs is assessed and the New Medicines Review recommendations are implemented, and notes the calls both for all eligible people in Lothian and across the country to have immediate access to these medicines to prevent further decline and for established bodies such as Cystic Fibrosis Trust UK and Cystic Fibrosis Registry to be asked to capture data and assess the real value of these new medicines.
Official Report
Meeting date:
24 September 2019
Health and Sport Committee 24 September 2019
I want to be clear that much of the workforce planning that would benefit emergency medicine is not workforce planning in emergency medicine.
Official Report
Meeting date:
8 October 2019
Meeting of the Parliament 08 October 2019
I thank the Institute of Occupational Medicine for all its skilled research and innovative, amazing work.
Questions and Answers
Date answered:
2 March 2020
S5W-27110
The safe and effective management of medicines is overseen through the Health Boards' Medicines Governance Strategies and implemented locally under Safe Use of Medicines protocols and Clinical Governance frameworks.
